“A Case Report on Therapeutic Optimization and Cardiometabolic Benefits of Semaglutide Therapy in Type 2 Diabetes Mellitus: Case Report”. Journal of Pharma Insights and Research 4, no. 2 (April 5, 2026): 252–258. Accessed May 19, 2026. https://staging.jopir.in/index.php/journals/article/view/742.